The development of fine motor skill could take longer than previously thought, according to a new study.
Researchers discovered a novel molecular target for the design of drugs which could be safer and more effective for multiple sclerosis, as well as other disorders associated with the loss of white matter in the brain.
Scientists report researchers are now on the threshold of human application of stem cell therapies for a class of neurological diseases known as myelin disorders – a long list of diseases that include conditions such as multiple sclerosis, white matter stroke, cerebral palsy, certain dementias, and rare but fatal childhood disorders called pediatric leukodystrophies.
A team of scientists from Johns Hopkins and elsewhere have developed nano-devices that successfully cross the brain-blood barrier and deliver a...
The world's first basic research institute for childhood neurological diseases opened in Houston, Texas and is part of the Texas Children's Hospital. Some of the research the new research insitute will focus on includes childhood neurological diseases such as autism, epilepsy, Rett syndrome, cerebral palsy, ataxias and Batten disease. More details about the new institute are provided in the press release below.
